Surrogate markers of atherosclerosis: impact of statins

John J.P. Kastelein, Albert Wiegman, Eric de Groot
  • Atherosclerosis Supplements, March 2003, Elsevier
  • DOI: 10.1016/s1567-5688(03)00007-2
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Albert Wiegman